‘Our Second COVID-19 Vaccine Is 100% Effective’, Says Russia

January 19, 2021
39 Views

By Onwuka Gerald

Russia’s second to be registered COVID-19 vaccine, EpiVacCorona, proved 100% effective in early-stage trials, said Russian consumer health watchdog Rospotrebnadzor.

The data, based on Phase I and II trials, were released before the start of a larger Phase III trial which normally would involve thousands of participants.

Citing Rospotrebnadzor, the TASS news agency reported, that the potency of the vaccine is made up of its immunological effectiveness and preventative effectiveness”.

They said, “According to results of the first and second phases of clinical trials, the immunological response of the EpiVacCorona vaccine is 100% effective”.

Russia started testing EpiVacCorona, which is being developed by Siberia’s Vector Institute, in November 2020.

Meanwhile, Moscow in early November said its other approved vaccine, Sputnik V, was 92% effective at protecting people from contracting the virus.

You may be interested

Trending: Meet couple who joined Police, became Commissioners ‘same day’
News
4 views
News
4 views

Trending: Meet couple who joined Police, became Commissioners ‘same day’

Webby - January 15, 2022

The Inspector-General of Police (IGP) Usman Baba on Friday decorated Kehinde Patrick Longe and his wife, Yetunde Longe as Commissioners…

Rice festival and Buhari’s obsession with agriculture – By Khalifa Nuruddeen Abande
News
News

Rice festival and Buhari’s obsession with agriculture – By Khalifa Nuruddeen Abande

Webby - January 14, 2022

/* custom css */ .tdi_59.td-a-rec{ text-align: center; }.tdi_59 .td-element-style{ z-index: -1; }.tdi_59.td-a-rec-img{ text-align: left; }.tdi_59.td-a-rec-img img{ margin: 0 auto 0…

Investors groan as Nigeria’s stock extends bearish run
Business
4 views
Business
4 views

Investors groan as Nigeria’s stock extends bearish run

Webby - January 14, 2022

Spread the love The Nigerian stock market ended in the red zone on Friday following the crash in equity capitalization…

Leave a Comment

Your email address will not be published.